BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20183466)

  • 1. Missing data handling methods in medical device clinical trials.
    Yan X; Lee S; Li N
    J Biopharm Stat; 2009 Nov; 19(6):1085-98. PubMed ID: 20183466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing data in the regulation of medical devices.
    Campbell G; Pennello G; Yue L
    J Biopharm Stat; 2011 Mar; 21(2):180-95. PubMed ID: 21390995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation.
    Li X; Wang WW; Liu GF; Chan IS
    J Biopharm Stat; 2011 Mar; 21(2):294-310. PubMed ID: 21391003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missing inaction: preventing missing outcome data in randomized clinical trials.
    Wittes J
    J Biopharm Stat; 2009 Nov; 19(6):957-68. PubMed ID: 20183458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dealing with missing outcome data in randomized trials and observational studies.
    Groenwold RH; Donders AR; Roes KC; Harrell FE; Moons KG
    Am J Epidemiol; 2012 Feb; 175(3):210-7. PubMed ID: 22262640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases.
    Baron G; Boutron I; Giraudeau B; Ravaud P
    Arthritis Rheum; 2005 Jun; 52(6):1858-65. PubMed ID: 15934058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a binary composite endpoint with missing data in components.
    Quan H; Zhang D; Zhang J; Devlamynck L
    Stat Med; 2007 Nov; 26(26):4703-18. PubMed ID: 17431851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome.
    Hall SM; Delucchi KL; Velicer WF; Kahler CW; Ranger-Moore J; Hedeker D; Tsoh JY; Niaura R
    Nicotine Tob Res; 2001 Aug; 3(3):193-202. PubMed ID: 11506764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical analysis of clinical trials.
    Wassertheil-Smoller S; Kim MY
    Semin Nucl Med; 2010 Sep; 40(5):357-63. PubMed ID: 20674595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing... presumed at random: cost-analysis of incomplete data.
    Briggs A; Clark T; Wolstenholme J; Clarke P
    Health Econ; 2003 May; 12(5):377-92. PubMed ID: 12720255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing data in confirmatory clinical trials.
    Flyer P; Hirman J
    J Biopharm Stat; 2009 Nov; 19(6):969-79. PubMed ID: 20183459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methods for handling missing data in clinical trials influence sample size requirements.
    Auleley GR; Giraudeau B; Baron G; Maillefert JF; Dougados M; Ravaud P
    J Clin Epidemiol; 2004 May; 57(5):447-53. PubMed ID: 15196614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of longitudinal binary data with missing data due to dropouts.
    Ali MW; Talukder E
    J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trials.
    Bhattacharya S; Fyfe G; Gray RJ; Sargent DJ
    J Clin Oncol; 2009 Dec; 27(35):5958-64. PubMed ID: 19826121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertainty method improved on best-worst case analysis in a binary meta-analysis.
    Gamble C; Hollis S
    J Clin Epidemiol; 2005 Jun; 58(6):579-88. PubMed ID: 15878471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcome.
    Hollis S
    Stat Med; 2002 Dec; 21(24):3823-34. PubMed ID: 12483769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.